Richard Acton
Impact in
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
- Mitochondrial Function and Pathology 2
- Cancer-related gene regulation 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
- Co-authors
- Christopher G. Bell (4 shared papers)Yudong Xia (2 shared papers)Jordana T. Bell (2 shared papers)Fei Gao (2 shared papers)Jun Wang (2 shared papers)Pirro G. Hysi (2 shared papers)Tim D. Spector (2 shared papers)Leonie Roos (1 shared paper)
- Journals
- Nature Communications (3 papers)Science Advances (2 papers)Clinical Epigenetics (1 paper)Molecular Systems Biology (1 paper)Cell Reports (1 paper)
- Partner nations
- United KingdomGermanyPoland
In The Last Decade
Richard Acton
11 papers receiving 289 citations
Peers
Comparison fields: 5 of 86
- Developmental Neuroscience 19
- Aging 7
- Molecular Biology 116
- Structural Biology 2
- Materials Chemistry 49
Countries citing papers authored by Richard Acton
This map shows the geographic impact of Richard Acton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Acton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Acton more than expected).
Fields of papers citing papers by Richard Acton
This network shows the impact of papers produced by Richard Acton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Acton. The network helps show where Richard Acton may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Acton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 142 | |
| 2 | 2022 | 39 | |
| 3 | 2022 | 36 | |
| 4 | 2021 | 18 | |
| 5 | 2025 | 17 | |
| 6 | 2023 | 13 | |
| 7 | 2022 | 12 | |
| 8 | 2017 | 4 | |
| 9 | 2024 | 4 | |
| 10 | 2025 | 4 | |
| 11 | To Go Free | 1989 | 2 |
About Richard Acton
Richard Acton is a scholar working on Molecular Biology, Infectious Diseases, Aging, Immunology and Developmental Neuroscience, having authored 11 papers that have together received 291 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Mitochondrial Function and Pathology (2 papers), Immune responses and vaccinations (2 papers), Cancer-related gene regulation (2 papers), COVID-19 Clinical Research Studies (1 paper) and Genetic Syndromes and Imprinting (1 paper). The work is most often cited by research in Developmental Neuroscience (19 citations), Aging (7 citations), Molecular Biology (116 citations), Structural Biology (2 citations) and Materials Chemistry (49 citations). Richard Acton has collaborated with scholars based in United Kingdom, Germany and Poland. Frequent co-authors include Christopher G. Bell, Yudong Xia, Jordana T. Bell, Fei Gao, Jun Wang, Pirro G. Hysi, Tim D. Spector, Leonie Roos, Massimo Mangino and Kirsten J. Ward. Their work appears in journals such as Nature Communications, Science Advances, Clinical Epigenetics, Molecular Systems Biology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.